Cargando…

Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer

Pertaining to the female population in the USA, breast cancer is the leading cancer in terms of annual incidence rate and, in terms of mortality, the second most lethal cancer. There are currently no biomarkers available that can predict which breast cancer patients will respond to chemotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikas, Jason B., Low, Walter C., Burgio, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355866/ https://www.ncbi.nlm.nih.gov/pubmed/22619502 http://dx.doi.org/10.4137/BMI.S9387

Ejemplares similares

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
por: Gass, Paul, et al.
Publicado: (2018)

Linear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
por: Gonzalez-Angulo, Ana M, et al.
Publicado: (2011)

Clinical and Therapeutic Factors Vary by Prognosis in Patients with Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer
por: Huang, Zhenfeng, et al.
Publicado: (2021)

Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
por: Zhu, Jiujun, et al.
Publicado: (2020)

Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer
por: Meng, Xiangyu, et al.
Publicado: (2022)

The evolving role of pathologic complete response in breast cancer
por: Hariharan, Nisha, et al.
Publicado: (2019)

Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
por: Zhao, Yue, et al.
Publicado: (2019)

Impact of Pathologic Complete Response on the Prognosis of Triple-Negative Breast Cancer Patients: A Cohort Study
por: Assunção Ribeiro da Costa, Rafael Everton, et al.
Publicado: (2023)

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
por: Ring, A E, et al.
Publicado: (2004)

Pathological complete response in younger and older breast cancer patients
por: Kołacińska, Agnieszka, et al.
Publicado: (2012)

Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy
por: Ryu, Young Jae, et al.
Publicado: (2018)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
por: Hong, Jin, et al.
Publicado: (2021)

Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer
por: Yan, Shuai, et al.
Publicado: (2020)

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
por: Zhao, Yue, et al.
Publicado: (2015)

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer
por: Pennisi, Angela, et al.
Publicado: (2016)

Accuracy of Tumor Bed Biopsy for Predicting Pathologic Complete Response After Chemotherapy Among Women With Breast Cancer: Complete Responders in the Breast Study
por: Hariharan, Nisha, et al.
Publicado: (2023)

Ki-67 and Its Relation With Complete Pathological Response in Patients With Breast Cancer
por: Wajid, Sana, et al.
Publicado: (2021)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Complete pathological response of NSCLC
por: Kovács, K, et al.
Publicado: (2013)

Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
por: Li, Xianjun, et al.
Publicado: (2020)

Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients
por: Sasanpour, Pegah, et al.
Publicado: (2018)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021)

Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer
por: Han, Yiqun, et al.
Publicado: (2021)

An unusual case of complete pathological response to Paget’s disease of the breast
por: Okonofua, Daisy, et al.
Publicado: (2022)

Pathological complete response in multimodal treatment of esophageal cancer: a retrospective cohort study
por: Hipp, Julian, et al.
Publicado: (2022)

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
por: Goorts, Briete, et al.
Publicado: (2018)

MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer
por: García-Vázquez, Raúl, et al.
Publicado: (2019)

Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with complete/near complete clinical and radiological response (Complete Responders in the Breast – CRBr) – Trial design and conduct
por: Hariharan, N., et al.
Publicado: (2019)

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
por: Boughey, Judy C., et al.
Publicado: (2018)

Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
por: Byrski, Tomasz, et al.
Publicado: (2015)

Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer
por: Silva, Luana Carolina Ferreira Fiuza, et al.
Publicado: (2019)

Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia
por: Rodríguez, Mauricio, et al.
Publicado: (2023)

High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer
por: Alba, Emilio, et al.
Publicado: (2016)

Clinical N3 is an independent risk factor of recurrence for breast cancer patients achieving pathological complete response and near-pathological complete response after neoadjuvant chemotherapy
por: Qian, Xiaoyan, et al.
Publicado: (2022)

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
por: KAWAJIRI, HIDEMI, et al.
Publicado: (2014)

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
por: Santonja, Angela, et al.
Publicado: (2018)

Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Nakashoji, Ayako, et al.
Publicado: (2017)

Gene signatures in patients with early breast cancer and relapse despite pathologic complete response
por: Bruzas, Simona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mj0sgub59ahfkgpun8gth2g5qe